SCOTTSDALE, Ariz., Oct. 17 /PRNewswire-FirstCall/ -- Motion DNA Corporation has announced an increase in revenues for 2005. In 2004 the company generated just over $1.4 Million through the entire year, with the majority of the income produced in the final quarter of 2004. The company's assets currently total $1.2 million.
The company is currently ahead of last year's annual revenue with just over $1.5 million in revenue through the first three quarters of 2005. Company officials expect to reach their revenue goals of $3M in revenue this year with the launch of an intense marketing campaign and the majority of its revenue generating events scheduled for November and December of 2005.
To view the reports, please copy and paste the following address into your browser: http://www.pinksheets.com/quote/finance.jsp?symbol=MTDX
About Motion DNA:
Motion DNA Corporation provides diagnostic testing for medical professionals and sports organizations. Motion DNA's biomechanical analyses and detailed reports provide its customers and consumers with solutions for preventing injuries, identifying physical limitations, diagnosing preexisting injuries related to biomechanics, and improving physical performance levels. The company's technology will be available for sale beginning in December of 2005. For additional information on the company, please visit the company website at www.motiondnacorp.com.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors. The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
Mr. Zig Ziegler, President
AGORA Investor Relations
Motion DNA Corporation
CONTACT: Zig Ziegler, President of Motion DNA Corporation,+1-480-425-7734, email@example.com; or Investor Relations, AGORAInvestor Relations, MTDX@Agoracom.com, for Motion DNA Corporation